Physical–chemical properties of furosemide nanocrystals developed using rotation revolution mixer

References

• World Health Organization – WHO. WHO model list of essential medicines [Place unknown]; 2013. Available from: http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1 [last accessed 23 Mar 2014]
   Google Scholar
• Pacifi GM. Clinical pharmacology of furosemide in neonates: a review. Pharmaceuticals 2013;6:1094–1129
   Google Scholar
• Clear NJ, Milton A, Humphrey M, et al. Evaluation of the intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon. Eur J Pharm Sci 2001;13:375–384
   PubMed Web of Science ®Google Scholar
• Murray MD, Haag KM, Black PK, et al. Variable furosemide absorption and poor predictability of response in elderly patient. Pharmacotherapy 1997;17:98–106
   PubMed Web of Science ®Google Scholar
• Granero GE, Longhi MR, Mora MJ, et al. Biowaiver monographs for immediate release solid oral dosage forms: furosemide. J Pharm Sci 2010;99:2544–2556
   PubMed Web of Science ®Google Scholar
• Lipinski C. Poor aqueous solubility-an industry wide problem in drug discovery. Am Pharm Rev 2002;5:82–85
   Google Scholar
• Müller RH, Keck CM. Twenty years of drug nanocrystals: where are we, and where do we go? Eur J Pharm Biopharm 2012;80:1–3
   PubMed Web of Science ®Google Scholar
• Perioli L, D'alba G, Pagano C. New oral solid dosage form for furosemide oral administration. Eur J Pharm Biopharm 2012;80:621–629
   PubMed Web of Science ®Google Scholar
• Ambrogi V, Perioli L, Pagano C, et al. Use of SBA-15 for furosemide oral delivery enhancement. Eur J Pharm Sci 2012;43:46–48
   Google Scholar
• Goud NR, Gangavaram S, Suresh K, et al. Novel furosemide cocrystals and selection of high solubility drug forms. J Pharm Sci 2012;101:664–680
   PubMed Web of Science ®Google Scholar
• Zordi N, Moneghini M, Kikic I, et al. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions. Eur J Pharm Biopharm 2012;81:131–141
   PubMed Web of Science ®Google Scholar
• Takatsuka T, Endo T, Jianguo Y, et al. Nanosizing of poorly water soluble compounds using rotation revolution mixer. Chem Pharm Bull 2009;57:1061–1067
   PubMed Web of Science ®Google Scholar
• Yuminoki K, Takeda M, Kitamura K, et al. Nano-pulverization of poorly water soluble compounds with low melting points by a rotation revolution pulverizer. Pharmazie 2012;67:681–686
   PubMed Web of Science ®Google Scholar
• Song J, Wang Y, Song Y, et al. Development and characterisation of ursolic acid nanocrystals without stabilizer having improved dissolution rate and in vitro anticancer activity. AAPS PharmSciTech 2014;15:11–19
   PubMed Web of Science ®Google Scholar
• Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 2010;399:129–139
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, et al. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharm Res 2013;30:307–324
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Kenneth C. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Cundy Int J Pharm 1995;125:91–97
   Web of Science ®Google Scholar
• Crisp MT. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals. J Control Release 2007;117:351–359
   PubMed Web of Science ®Google Scholar
• Müller RH, Keck C. Improvement of delivery & solubility of poorly soluble drugs by nanonization. Petersburg: LTS Academy; 2007
   Google Scholar
• Müller RH, Akkar A. Drug nanocrystals of poorly soluble drugs. In: Nalwa HS, ed. Encyclopedia of nanoscience and nanotechnology. Los Angeles: American Scientific Publishers; 2004:627–628
   Google Scholar
• Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs. Preparation by a size-reduction technique. Int J Pharm 1998;160:229–237
   Web of Science ®Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008;364:64–75
   PubMed Web of Science ®Google Scholar
• Müller RH, Gohla S, Keck CM. State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm 2011;78:1–9
   PubMed Web of Science ®Google Scholar
• Möschwitzer J. Nanotechnology: particle size reduction technologies in the pharmaceutical development process. Am Pharm Rev 2010;4:54–59
   Google Scholar
• Junghanns JU, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 2008;3:295–309
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 2008;36:43–48
   PubMed Web of Science ®Google Scholar
• Mauludin R, Kobierski S, Knauer J, Müller RH. Dissolution velocity of coenzyme Q10 nanocrystal-loaded capsules. International Symposium on Controlled Release of Bioactive Materials, New York City, 2008, 35 p
   Google Scholar
• Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–934
   Google Scholar
• Salazar J, Ghanem A, Müller RH, Möschwitzer JP. Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. Eur J Pharm Biopharm 2012;81:82–90
   PubMed Web of Science ®Google Scholar
• Bartolomei M, Bertocchi P, Antoniella E, Rodomonte A. Physico-chemical characterisation and intrinsic dissolution studies of a new hydrate form of diclofenac sodium: comparison with anhydrous form. J Pharm Biomed Anal 2006;40:1105–1113
   PubMed Web of Science ®Google Scholar
• Ponchel G, Montisci MJ, Dembri A, et al. Mucoadhesion of colloidal particulate systems in the gastrointestinal tract. Eur J Pharm Biopharm 1997;44:25–31
   Web of Science ®Google Scholar
• Temtem M, Neves F, Winters C. Bridging API manufacturing and formulation through particle design. Eur Ind Pharm 2013;17:13–17
   Google Scholar
• Vehring R. Red-excitation dispersive raman spectroscopy is a suitable technique for solid state analysis of respirable pharmaceutical powders. Appl Spectrosc 2005;59:286–292
   PubMed Web of Science ®Google Scholar
• Vehring R, Ivey J, Williams L, et al. High-sensitivity analysis of crystallinity in respirable powders using low frequency shift-raman spectroscopy. Respir Drug Deliv 2012;2:641–644
   Google Scholar
• Lobënberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classifications system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3–12
   PubMed Web of Science ®Google Scholar
• The United States Pharmacopeia (USP 38). Rockville (MD): United States Pharmacopeia Convention, Inc.; 2015
   Google Scholar
• Bolton S. Statistics. In: Allen LV, ed. Remington: the science and practice of pharmacy. 20th ed. Philadelphia: Lippincott Williams & Wilkins; 2000:127--161
   Google Scholar
• Matsuda Y, Tatsumi E. Physicochemical characterization of furosemide modifications. Int J Pharm 1990;60:11–26
   Web of Science ®Google Scholar
• Trasi NS, Boerrigter SXM, Byrn SR, Carvajal TM. Investigating the effect of dehydration conditions on the compactability of glucose. Int J Pharm 2011;406:55–61
   PubMed Web of Science ®Google Scholar
• Mauludin R, Müller RH. Physicochemical properties of hesperidin nanocrystal. Int J Pharm Pharm Sci 2013;5:954–960
   Google Scholar
• Mauludin R, Müller RH, Keck CM. Development of an oral rutin nanocrystal formulation. Int J Pharm 2009;370:202–219
   PubMed Web of Science ®Google Scholar
• Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004;3:785–796
   PubMed Web of Science ®Google Scholar
• Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm 2009;371:185–198
   Web of Science ®Google Scholar
• Li M, Yaragudi N, Afolabi A, et al. Sub-100nm drug particle suspensions prepared via wet milling with low bead contamination through novel process intensification. Chem Eng Sci 2015;130:207–220
   Web of Science ®Google Scholar
• Letellier P, Mayaffre A, Turmine M. Drop size effect on contact angle explained by nonextensive thermodynamics. Young's equation revisited. J Coll Int Sci 2007;314:604–614
   PubMed Web of Science ®Google Scholar
• Liu X, Yang P, Jiang Q. Size effect on melting temperature of nanostructured drugs. Mater Chem Phys 2007;103:1–4
   Web of Science ®Google Scholar
• Chu KA, Yalkowsky SH. An interesting relationship between drug absorption and melting point. In J Pharm 2009;373:24–40
   Google Scholar
• Ge M, Liu G, Ma S, Wang W. Polymorphic forms of furosemide characterized by THz Time Domain spectroscopy. Bull Korean Chem Soc 2009;30:2265–2268
   Web of Science ®Google Scholar
• Babu NJ, Cherukuvada S, Thakuria R, Nangia A. Conformational and synthon polymorphism in furosemide (Lasix). Cryst Growth Des 2010;10:1979–1989
   Web of Science ®Google Scholar
• Möschwistzer J, Müller RH. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. Eur J Pharm Biopharm 2006;62:282–287
   PubMed Web of Science ®Google Scholar
• Ravichandran R. In vivo pharmacokinetic studies of albendazole nanoparticulate oral formulations for improved bioavailability. Int J Green Nanotechnol Biomed 2010;2:B46–B53
   Google Scholar
• Xiong R, Lu W, Li J, et al. Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm 2008;350:338–343
   PubMed Web of Science ®Google Scholar
• Pardeike J, Müller RH. Nanosuspensions: a promising formulation for the new phospholipase A 2 inhibitor PX-18. Int J Pharm 2010;391:322–329
   PubMed Web of Science ®Google Scholar
• Yu LA, Carlin AS, Amidon GL, Hussain AS. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. Int J Pharm 2004;270:221–227
   PubMed Web of Science ®Google Scholar
• Chemicalize.org. [Place unknown]; 2014. Available from: http://www.chemicalize.org/structure/#!mol=furosemide&source=fp [last accessed 5 Jun 2015]
   Google Scholar
• Liu X, Testa B, Fahr A. Lipophilicity and its relationship with passive drug permeation. Pharm Res 2011;28:962–977
   PubMed Web of Science ®Google Scholar
• Rege, BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002;16:237–246
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, et al. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm 2004;278:119–131
   PubMed Web of Science ®Google Scholar
• Al-Mohizea AM. Influence of intestinal efflux pumps on the absorption and transport of furosemide. Saudi Pharm J 2010;18:97–101
   PubMedGoogle Scholar
• Roa WH, Azarmi S, Al-Hallak MHDK, et al. Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J Control Release 2011;150:49–55
   PubMed Web of Science ®Google Scholar
• Ghirardelli R, Bonasoro F, Porta C, Cremaschi D. Identification of particular epithelial areas and cells that transport polypeptide-coated nanoparticles in the nasal respiratory mucosa of the rabbit. Biochim Biophys Acta 1999;1416:39–47
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823–839
   PubMed Web of Science ®Google Scholar
• Rogueda PG, Traini D. The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects. Expert Opin Drug Deliv 2007;4:595–606
   PubMed Web of Science ®Google Scholar
• Yang JZ, Young AL, Chiang PC, et al. Fluticasone and budesonide nanosuspensions for pulmonary delivery: preparation, characterization, and pharmacokinetic studies. J Pharm Sci 2008;97:4869–4878
   PubMed Web of Science ®Google Scholar
• Garnero C, Chattah AK, Longhi M. Supramolecular complexes of maltodextrin and furosemide polymorphs: a new approach for delivery systems. Carbohydr Polym 2013;94:292–300
   PubMed Web of Science ®Google Scholar